Th1 Chemokine CXCL10 and Alopecia Areata: A Possible Target for Treatment

January 2016 in “ Journal of Clinical & Cellular Immunology ”

Taisuke Ito, Toshiharu Fujiyama, Y. Tokura

alopecia areata CXCL10 Th1 chemokine CXCR3 CD4+ T cells CD8+ T cells chemotactic activity antihistaminic drugs olopatadine AA Th1-associated chemokine T cells antihistamines

TLDR Targeting CXCL10 may help treat alopecia areata.

The study explored the role of the Th1-associated chemokine CXCL10 in alopecia areata (AA), an autoimmune disease characterized by hair loss. It was found that in acute-phase AA, hair follicles expressed high levels of CXCL10, attracting CXCR3+CD4+ and CXCR3+CD8+ T cells, which contributed to the "swarm of bees" appearance around hair bulbs. In chronic-phase AA, CXCR3+CD8+ T cells dominated, potentially prolonging hair loss. The study suggested that targeting the chemotactic activity of CXCL10 could be a novel treatment approach for AA. Antihistaminic drugs like olopatadine showed potential in reducing this chemotactic activity by affecting CXCR3 expression and related cellular processes.

View this study on longdom.org →

Discuss this study in the Community →

Research cited in this study

17 / 17 results

research Efficacy of Tofacitinib in Treatment of Alopecia Universalis in Two Patients

51 citations , June 2016 in “Journal of the European Academy of Dermatology and Venereology”

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

research Familial Aggregation of Alopecia Areata

295 citations , May 2016 in “Journal of the American Academy of Dermatology”

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

research Multiple Courses of Pulse Corticosteroid Therapy for Alopecia Areata

15 citations , April 2016 in “The Journal of Dermatology”

Multiple courses of pulse corticosteroid therapy improve hair growth in alopecia areata patients with minimal side effects.

research Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition

701 citations , August 2014 in “Nature medicine”

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

research Lichen Planopilaris Is Characterized By Immune Privilege Collapse Of The Hair Follicle's Epithelial Stem Cell Niche

220 citations , June 2013 in “The Journal of Pathology”

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

research British Association of Dermatologists’ Guidelines for the Management of Alopecia Areata 2012

218 citations , April 2012 in “British Journal of Dermatology”

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

research Advances in the Management of Alopecia Areata

51 citations , December 2011 in “The Journal of Dermatology”

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Transcriptional Profiling in Alopecia Areata Defines Immune and Cell Cycle Control Related Genes Within Disease-Specific Signatures

research Transcriptional Profiling in Alopecia Areata Defines Immune and Cell Cycle Control Related Genes Within Disease-Specific Signatures

61 citations , September 2010 in “Genomics”

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

research Immune Privilege and Alopecia Areata

4 citations , April 2010 in “Expert review of dermatology”

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

research Experimental Evaluation of Ebastine, a Second-Generation Antihistamine, as a Supportive Medication for Alopecia Areata

35 citations , March 2010 in “Journal of Dermatological Science”

Ebastine may help regrow hair in alopecia areata patients.

research Expression of Snail1 in the Fibrotic Dermis of Postmenopausal Frontal Fibrosing Alopecia: Possible Involvement of an Epithelial-Mesenchymal Transition and a Review of Japanese Patients

29 citations , February 2010 in “British Journal of Dermatology”

Snail1 may contribute to fibrosis in frontal fibrosing alopecia in postmenopausal women.

research Alopecia Areata Update

391 citations , January 2010 in “Journal of The American Academy of Dermatology”

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Treatment of Postmenopausal Frontal Fibrosing Alopecia with Oral Dutasteride